Brief: BioNTech Holds 8.29% Stake In Ryvu Therapeutics
19/01/2023 16:11
Jan 19 (Reuters) - Ryvu Therapeutics RVU.WA :
* BIONTECH NOW HOLDS 8.29% STAKE IN COMPANY FOLLOWING
REGISTRATION
OF J SERIES SHARES
Source text for Eikon: ID:nEM2Yzwnba
Further company coverage: RVU.WA 22UAy.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project